January 27, 2025 Non Regulatory Promising results from AcuCort’s Phase IV study – scientific articles under preparation for international publication
January 17, 2025 Regulatory AcuCort’s Chairman subscribes for an additional approximately SEK 200,000 in the ongoing rights issue
January 14, 2025 Regulatory AcuCort’s CEO subscribes for an additional SEK 1 million in the ongoing rights issue, bringing total commitment to approximately SEK 2 million